Cambrex logo

CBM - Cambrex Share Price

$59.99 0.0  0.0%

Last Trade - 03/12/19

Sector
Healthcare
Size
Micro Cap
Market Cap £n/a
Enterprise Value £n/a
Revenue £474.0m
Position in Universe th / 6381
Bullish
Bearish
Unlock CBM Revenue
Momentum
Relative Strength (%)
1m -4.25%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2013 2014 2015 2016 2017 2018 2019E 2020E CAGR / Avg
318.2 374.6 433.3 490.6 534.5 532.1 648.7 659.7 +10.8%
-58.0 +123.2 +5.2 +30.5 +15.3 -3.7 -28.5 -3.28
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the nine months ended 30 September 2019, Cambrex Corporation revenues increased 22% to $484.9M. Net income before extraordinary items decreased 62% to $34.6M. Revenues reflect North America segment increase from $127.3M to $261M, Asia segment increase of 53% to $17.2M. Net income was offset by Other Selling, General and admin Exp increase of 66% to $72.7M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

CBM Revenue Unlock CBM Revenue

Net Income

CBM Net Income Unlock CBM Revenue

Normalised EPS

CBM Normalised EPS Unlock CBM Revenue

PE Ratio Range

CBM PE Ratio Range Unlock CBM Revenue

Dividend Yield Range

CBM Dividend Yield Range Unlock CBM Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2020
31st Dec 2021
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
CBM EPS Forecasts Unlock CBM Revenue
Profile Summary

Cambrex Corporation (Cambrex) is a United States-based small molecule company providing drug substance, drug product and analytical services across the entire drug lifecycle. The company provides customers with an end-to-end partnership for the research, development and manufacture of small molecule therapeutics. The Company offers a range of specialist drug substance technologies and capabilities including biocatalysis, continuous flow, controlled substances, solid state science, material characterization and potent application program interface. In addition, it also supports conventional dosage forms including oral solids, semi-solids and liquids and has the capabilities to manufacture specialist dosage forms such as modified-release, fixed dose combination, pediatric, bi-layer tablets, stick packs, topicals, controlled substances, sterile and non-sterile ointments.

Directors
Last Annual December 31st, 2018
Last Interim September 30th, 2019
Incorporated October 11, 1983
Public Since September 23, 1987
No. of Shareholders: 22,572
No. of Employees: 1,732
Sector Healthcare
Industry Pharmaceuticals
Index
Exchange New York Stock Exchange
Shares in Issue 33,724,367
Free Float (0.0%)
Eligible for
ISAs
SIPPs
CBM Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for CBM
Upcoming Events for CBM
Frequently Asked Questions for Cambrex
What is the Cambrex share price?

As of 03/12/19, shares in Cambrex are trading at $59.99, giving the company a market capitalisation of £n/a. This share price information is delayed by 15 minutes.

How has the Cambrex share price performed this year?

Shares in Cambrex are currently trading at $59.99 and the price has moved by 21.78% over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Cambrex price has moved by 2.59% over the past year.

What are the analyst and broker recommendations for Cambrex?

Of the analysts with advisory recommendations for Cambrex, there are there are currently 0 "buy" , 4 "hold" and 0 "sell" recommendations. The overall consensus recommendation for Cambrex is Hold. You can view the full broker recommendation list by unlocking its StockReport.

When will Cambrex next release its financial results?

Cambrex is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2020-09-30
What is the Cambrex dividend yield?

Cambrex does not currently pay a dividend.

Does Cambrex pay a dividend?

Cambrex does not currently pay a dividend.

When does Cambrex next pay dividends?

Cambrex does not currently pay a dividend.

How do I buy Cambrex shares?

To buy shares in Cambrex you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Cambrex?

Shares in Cambrex are currently trading at $59.99, giving the company a market capitalisation of £n/a.

Where are Cambrex shares listed? Where are Cambrex shares listed?

Here are the trading details for Cambrex:

Country of listing: United States
Exchange: NYQ
Ticker Symbol: CBM
What kind of share is Cambrex?

We were not able to load our ranking data for Cambrex

Is there a Cambrex share price forecast 2020?

We were not able to load any forecast data for Cambrex.

How can I tell whether the Cambrex share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Cambrex. Over the past six months, the relative strength of its shares against the market has been 44.68%. At the current price of $59.99, shares in Cambrex are trading at % against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Cambrex PE Ratio?

We were not able to find PE ratio data for Cambrex.

Who are the key directors of Cambrex?

We were unable to find the directors for Cambrex.

Who are the major shareholders of Cambrex?

Here are the top five shareholders of Cambrex based on the size of their shareholding:

Similar to CBM
© Stockopedia 2020, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.